Anal cytology as a screening tool for early detection of anal dysplasia in HIV-infected women

Anticancer Research

Volumn 30, Issue 5, 2010, Pages 1719-1723

  Gingelmaier, Andrea ^a   Weissenbacher, Tobias ^a   Kost, Bernd ^a   Kaestner, Ralph ^a   Sovric, Milena ^a   Mylonas, Ioannis ^a   Friese, Klaus ^a   Bergauer, Florian ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Anal cytology; Anal dysplasia; HIV; HPV; Infection; Women

Indexed keywords

ADULT; ANAL DYSPLASIA; CD4 LYMPHOCYTE COUNT; CONFERENCE PAPER; CYTOLOGY; DYSPLASIA; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE STATUS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECTUM BIOPSY; RISK FACTOR; SCREENING TEST; UTERINE CERVICITIS; UTERINE CERVIX DYSPLASIA; VIRUS LOAD;

ADULT; ANAL CANAL; ANUS DISEASES; ANUS NEOPLASMS; BIOPSY; COHORT STUDIES; CYTOLOGICAL TECHNIQUES; FEMALE; HIV INFECTIONS; HUMANS; IMMUNE SYSTEM; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 77954568388     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. D'Souza G, Wiley DJ, Li X, Chmiel JS, Margolick JB, Cranston RD and Jacobson LP: Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 48: 491-499, 2008.
2. Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, Carter JJ, Porter PL, Galloway DA and McDougall JK: Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 101: 270-280, 2004.
3. Palefsky JM, Holly EA, Ralston ML, Da Costa M and Greenblatt RM: Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J Infect Dis 183: 383-391, 2001. (Pubitemid 32105597)
4. Lopez-Aldeguer J, Aguirrebengoa K, Arribas JR, Este JA and Kindelan JM: New targets and new drugs in the treatment of HIV. Enferm Infecc Microbiol Clin 23(Suppl 2): 33-40, 2005.
5. Piketty C, Selinger-Leneman H, Grabar S, Duvivier C, Bonmarchand M, Abramowitz L, Costagliola D and Mary-Krause M: Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy. AIDS 22: 1203-1211, 2008.
6. Hessol NA, Pipkin S, Schwarcz S, Cress RD, Bacchetti P and Scheer S: The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. Am J Epidemiol 165: 1143-1153, 2007.
7. Scholefield JH, Castle MT and Watson NF: Malignant transformation of high-grade anal intraepithelial neoplasia. Br J Surg 92: 1133-1136, 2005. (Pubitemid 41284878)
8. Watson AJ, Smith BB, Whitehead MR, Sykes PH and Frizelle FA: Malignant progression of anal intra-epithelial neoplasia. ANZ J Surg 76: 715-717, 2006.
9. Berry JM, Palefsky JM and Welton ML: Anal cancer and its precursors in HIV-positive patients: perspectives and management. Surg Oncol Clin N Am 13: 355-373, 2004.
10. AWMF-Leitlinie Nr. 015/027: Prävention, Diagnostik und Therapie der HPV-Infektion und präinvasiver Läsionen des weiblichen Genitale (http://leitlinien.net/).
11. Wright TC Jr, Cox JT, Massad LS, Twiggs LB and Wilkinson EJ: 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. J Am Med Assoc 287: 2120-2129, 2002.
12. Chin-Hong PV and Palefsky JM: Human papillomavirus anogenital disease in HIV-infected individuals. Dermatol Ther 18: 67-76, 2005.
13. Durante AJ, Williams AB, Da Costa M, Darragh TM, Khoshnood K and Palefsky JM: Incidence of anal cytological abnormalities in a cohort of human immunodeficiency virus-infected women. Cancer Epidemiol Biomarkers Prev 12: 638-642, 2003.
14. Chin-Hong PV and Palefsky JM: Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus. Clin Infect Dis 35: 1127-1134, 2002.
15. Berry JM, Palefsky JM, Jay N, Cheng SC, Darragh TM and Chin-Hong PV: Performance characteristics of anal cytology and human papillomavirus testing in patients with high-resolution anoscopy-guided biopsy of high-grade anal intraepithelial neoplasia. Dis Colon Rectum 52: 239-247, 2009.
16. Lillo FB, Fenari D, Veglia F, Origoni M, Grasso MA, Lodini S, Mastrorilli E, Taccagni G, Lazzarin A and Uberti-Foppa C: Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. J Infect Dis 18: 547-551, 2001. (Pubitemid 32783544)
17. Minkoff H, Ahdieh L, Massad LS, Anastos K, Watts DH, Melnick S, Muderspach L, Burk R and Palefsky J: The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. AIDS 15: 2157-2164, 2001.
18. Palefsky JM: Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy. Curr Opin Oncol 15: 382-388, 2003.
19. Piketty C and Kazatchkine MD: Human papillomavirus-related cervical and anal disease in HIV-infected individuals in the era of highly active antiretroviral therapy. Curr HIV/AIDS Rep 2: 140-145, 2005.
20. Piketty C, Darragh TM, Heard I, Da Costa M, Bruneval P, Kazatchkine MD and Palefsky JM: High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex Transm Dis 31: 96-99, 2004.